Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients

被引：0
|
作者：
Kumano, K
Irie, A
Mashimo, S
Endo, T
Koshiba, K
机构：
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1354 / 1355
页数：2
相关论文
共 50 条
  • [41] MINNESOTA ALG VERSUS OKT3 AS TREATMENT FOR STEROID RESISTANT REJECTION IN RENAL-TRANSPLANT PATIENTS MAINTAINED ON CYCLOSPORINE
    HODGE, E
    NOVICK, A
    LEWIS, R
    STEINMULLER, D
    STREEM, S
    CUNNINGHAM, R
    BAILEY, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 8 (06) : A9 - A9
  • [42] REVERSAL OF STEROID-RESISTANT AND ANTITHYMOCYTE GLOBULIN-RESISTANT ACUTE REJECTION CRISES IN RENAL-TRANSPLANTATION WITH MONOCLONAL-ANTIBODY (OKT3)
    PRIETO, C
    RODRIGUEZPATERNINA, E
    ANDRES, A
    MORALES, JM
    FARIAS, J
    MONTOYO, C
    REGUEIRO, JR
    RODICIO, JL
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) : 1753 - 1754
  • [43] Low-dose OKT3 is not effective in the treatment of steroid-resistant acute renal allograft rejections
    Lye, WC
    Vathsala, A
    Lee, WT
    Leong, SO
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3106 - 3107
  • [44] OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection
    Patschan, Daniel
    Kribben, Andreas
    Pietruck, Frank
    Lutz, Jens
    Binek, Matthias
    Philipp, Thomas
    Heemann, Uwe
    Witzke, Oliver
    NEPHRON CLINICAL PRACTICE, 2006, 103 (03): : C94 - C99
  • [45] Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy
    Millis, JM
    Cronin, DC
    Newell, KA
    Piper, JB
    Woodle, ES
    Bruce, DS
    Conjeevaram, H
    Baker, AL
    Thistlethwaite, JR
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1549 - 1549
  • [46] INCIDENCE AND OUTCOME OF OKT3 TREATMENT FOR EARLY STEROID-RESISTANT REJECTION FOLLOWING HEPATIC TRANSPLANTATION
    LANGE, D
    BECHSTEIN, WO
    BLUMHARDT, G
    LEMMENS, P
    SCHATTENFROH, N
    NEUHAUS, P
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (02) : 1870 - 1871
  • [47] ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation
    Uslu, A
    Tokat, Y
    Ok, E
    Unsal, A
    Ilkgul, O
    Kaplan, H
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (07) : 2805 - 2806
  • [48] OKT3 for steroid-resistant acute GvHD: A three-center experience.
    Hebart, H
    Gscheidle, H
    Holler, E
    Niederwieser, D
    Kolb, HJ
    Kanz, L
    Einsele, H
    BLOOD, 1998, 92 (10) : 451A - 451A
  • [49] OKT3 for steroid-resistant acute GvHD: A three-center experience.
    Hebart, H
    Gscheidle, H
    Holler, E
    Niederwieser, D
    Kolb, HJ
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S92 - S92
  • [50] Comparison of tacrolimus and OKT3 treatment of steroid-resistant acute hepatic allograft rejection in children GE loss.
    Thistlethwaite, JR
    Grewal, HP
    Bruce, D
    Cronin, D
    Whitington, PF
    Newell, K
    Kelly, S
    Alonso, E
    Oswald, K
    Woodle, ES
    Millis, JM
    HEPATOLOGY, 1997, 26 (04) : 424 - 424
12345